Stan S. Greenberg

1.8k total citations
98 papers, 1.5k citations indexed

About

Stan S. Greenberg is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, Stan S. Greenberg has authored 98 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Physiology, 26 papers in Cardiology and Cardiovascular Medicine and 24 papers in Biochemistry. Recurrent topics in Stan S. Greenberg's work include Nitric Oxide and Endothelin Effects (40 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Ischemia and Reperfusion (9 papers). Stan S. Greenberg is often cited by papers focused on Nitric Oxide and Endothelin Effects (40 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Ischemia and Reperfusion (9 papers). Stan S. Greenberg collaborates with scholars based in United States, Germany and Sweden. Stan S. Greenberg's co-authors include Jianming Xie, F.P.J. Diecke, Thomas D. Giles, Keith J. Peevy, Jie Ouyang, Xinfang Zhao, Jay K. Kolls, Steve Nelson, Elinor H. Cantor and Jifang Wang and has published in prestigious journals such as Gastroenterology, Circulation Research and The FASEB Journal.

In The Last Decade

Stan S. Greenberg

95 papers receiving 1.4k citations

Peers

Stan S. Greenberg
Anwar R. Baydoun United Kingdom
John R. Vane United Kingdom
Robert L. Minor United States
Karen L. Davis United States
Richard Bogle United Kingdom
P. Rösen Germany
Thérèse McCall United Kingdom
Anwar R. Baydoun United Kingdom
Stan S. Greenberg
Citations per year, relative to Stan S. Greenberg Stan S. Greenberg (= 1×) peers Anwar R. Baydoun

Countries citing papers authored by Stan S. Greenberg

Since Specialization
Citations

This map shows the geographic impact of Stan S. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan S. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan S. Greenberg more than expected).

Fields of papers citing papers by Stan S. Greenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan S. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan S. Greenberg. The network helps show where Stan S. Greenberg may publish in the future.

Co-authorship network of co-authors of Stan S. Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stan S. Greenberg. A scholar is included among the top collaborators of Stan S. Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan S. Greenberg. Stan S. Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermersch, Patrick, Giacomo P. Comi, Gavin Giovannoni, et al.. (2011). Tolerability profile of cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis: factors contributing to treatment completion overall and in patients with high disease activity in the 96-week CLARITY study. UCL Discovery (University College London). 1 indexed citations
2.
Rieckmann, Peter, G. Comi, Sandra Cook, et al.. (2009). Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study. UCL Discovery (University College London). 9 indexed citations
3.
Given, Michael B., et al.. (1998). Protein Kinase C Isozymes in Skeletal Muscles During the Early Stage of Genetic and Streptozocin Diabetes. Experimental Biology and Medicine. 218(4). 382–389. 10 indexed citations
4.
Greenberg, Stan S., Jie Ouyang, Xinfang Zhao, Jifeng Wang, & Thomas D. Giles. (1998). The Potential Mechanism of Induction of Inducible Nitric Oxide Synthase mRNA in Alveolar Macrophages by Lipopolysaccharide and Its Suppression by Ethanol, In Vivo. Alcoholism Clinical and Experimental Research. 22(Supplement 1). 260–260. 1 indexed citations
5.
Greenberg, Stan S., Jianming Xie, Xinfang Zhao, Jie Ouyang, & Thomas D. Giles. (1996). Anin VivoCytokine and Endotoxin-Independent Pathway for Induction of Nitric Oxide Synthase II mRNA, Enzyme, and Nitrate/Nitrite in Alveolar Macrophages. Biochemical and Biophysical Research Communications. 227(1). 160–167. 13 indexed citations
6.
Greenberg, Stan S., et al.. (1996). Ethanol Suppresses Endotoxin But Not Platelet Activating Factor‐Induced Hypotension and Nitric Oxide. Alcoholism Clinical and Experimental Research. 20(7). 1260–1268. 7 indexed citations
7.
Cai, Baiqiang, et al.. (1994). Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission. Canadian Journal of Physiology and Pharmacology. 72(7). 801–810. 14 indexed citations
8.
Spolarics, Z., et al.. (1993). Alcohol Administration Attenuates LPS-Induced Expression of Inducible Nitric Oxide Synthase in Kupffer and Hepatic Endothelial Cells. Biochemical and Biophysical Research Communications. 197(2). 606–611. 63 indexed citations
9.
Wang, Ye, Howard Lippton, Baiqiang Cai, et al.. (1993). Tumor Necrosis Factor Inhibits Stimulated but Not Basal Release of Nitric Oxide. American Review of Respiratory Disease. 148(3). 627–636. 24 indexed citations
10.
Xie, Jianming, Ye Wang, Warren R. Summer, & Stan S. Greenberg. (1993). Ouabain Enhances Basal Release of Nitric Oxide from Carotid Artery. The American Journal of the Medical Sciences. 305(3). 157–163. 28 indexed citations
11.
Greenberg, Stan S., et al.. (1991). Hemodynamic and Myocardial Energetic Effects of CK-3197, a Selective Positive Inotropic Agent. Journal of Cardiovascular Pharmacology. 17(1). 145–153. 4 indexed citations
12.
Greenberg, Stan S., et al.. (1991). Calcium-Dependent and Independent Mechanisms of Contraction in Canine Lingual Artery to U-46619. Advances in experimental medicine and biology. 304. 491–498. 2 indexed citations
13.
Greenberg, Stan S., et al.. (1991). Endothelium-Derived and Intraneuronal Nitric Oxide-Dependent Inhibition of Norepinephrine Efflux From Sympathetic Nerves by Bradykinin. American Journal of Hypertension. 4(5 Pt 1). 464–467. 29 indexed citations
14.
Greenberg, Stan S., et al.. (1990). Positive Inotropy Contributes to the Hemodynamic Mechanism of Action of Flosequinan (BTS 49465) in the Intact Dog. Journal of Cardiovascular Pharmacology. 15(6). 900–910. 17 indexed citations
15.
Greenberg, Stan S., et al.. (1990). Presynaptic Modulation of Sympathetic Neurotransmitter Release by Modulators of Cyclic 3′,5′‐Guanosine Monophosphate in Canine Vascular Smooth Musclea. Annals of the New York Academy of Sciences. 604(1). 305–322. 3 indexed citations
16.
Greenberg, Stan S., et al.. (1989). The endothelium modulates adrenergic neurotransmission to canine pulmonary arteries and veins. European Journal of Pharmacology. 162(1). 67–80. 62 indexed citations
18.
Greenberg, Stan S., Philip J. Kadowitz, & Thomas F. Burks. (1982). Prostaglandins, organ- and tissue-specific actions. M. Dekker eBooks. 1 indexed citations
19.
Greenberg, Stan S.. (1981). Effect of prostacyclin and 9a, 11a-epoxymethanoprostaglandin H2 on calcium and magnesium fluxes and tension development in canine intralobar pulmonary arteries and veins.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 326–337. 18 indexed citations
20.
Greenberg, Stan S., et al.. (1973). DIFFERENTIATION OF CALCIUM POOLS UTILIZED IN THE CONTRACTILE RESPONSE OF CANINE ARTERIAL AND VENOUS SMOOTH MUSCLE TO NOREPINEPHRINE. Journal of Pharmacology and Experimental Therapeutics. 185(3). 493–504. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026